Home › Funds › TCG Crossover Management, LLC › COGT

TCG Crossover Management, LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

TCG Crossover Management, LLC reported holding 4,854,436 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$187.9M, representing 4.52% of its reported portfolio and ranking #4 among its reported holdings. TCG Crossover Management, LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.85M sh
Reported value held$187.87M
Portfolio Weight4.52%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's COGT position evolved

TCG Crossover Management, LLC first disclosed a stake in COGT in Q3 2023 at 5,631,042 shares (US$54.9M). The position peaked in Q4 2025 at 5,868,162 shares, worth US$208.4M. Across 12 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,854,436 shares valued at US$187.9M — a reduction of -92,458 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.63M $54.90M New
Q4 2023 5.63M $33.11M Hold
Q1 2024 6.21M $41.76M Add
Q2 2024 6.96M $58.71M Add
Q3 2024 6.96M $75.22M Hold
Q4 2024 6.96M $54.32M Hold
Q1 2025 6.96M $41.72M Hold
Q2 2025 6.96M $50.00M Hold
Q3 2025 6.80M $97.62M Reduce
Q4 2025 5.87M $208.44M Reduce
Q1 2026 4.95M $190.41M Reduce
Q2 2026 4.85M $187.87M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), Kynam Capital Management, LP (US$141.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has TCG Crossover Management, LLC held COGT?

TCG Crossover Management, LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TCG Crossover Management, LLC's current position in COGT?

As of Q2 2026, TCG Crossover Management, LLC holds 4.85M shares of COGT (COGENT BIOSCIENCES INC), valued at $187.87M, representing 4.52% of its reported portfolio and ranking #4.

Has TCG Crossover Management, LLC been buying or selling COGT?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC reduced its position in COGT. The position peaked in Q4 2025 at 5.87M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., Kynam Capital Management, LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.